Cofounders' exit raises concerns among investors.
Company's financial outlook falls short of market forecasts.
Stock price experiences significant decline.
Briefing: BioNTech Shares Fall After Cofounders Plan Exit, Outlook Misses Forecasts
Strategic angle: BioNTech's stock takes a hit as cofounders announce their departure and the company's outlook fails to meet expectations.